Table 4.

PMLRARm4 leukemias bone marrow

MiceBlast + Pro Imm Neut Mat Neut Erythroid LymphEosin
Control  2.0 ± 0.7  16.4 ± 2.4  27.0 ± 5.0   40.3 ± 6.5  12.1 ± 1.9 2.3 ± 0.9  
PR  81.3 ± 8.1   4.5 ± 2.6 0.7 ± 0.7   8.7 ± 7.7   4.5 ± 2.2 0.3 ± 0.3  
PRm4  65.7 ± 27.1  13.1 ± 14.4 12.7 ± 17.5   3.5 ± 2.4   4.4 ± 2.4 0.5 ± 1.1  
Leukemia  
 4042  44.5  37.5  5.5 4  6  2.5  
 4048.3  66.5  11  15.5  0.5 6.5  0  
 4048.5  94.5  0.5  0  3.5  1.5  
 4099  90  4.5  0.5  2.5  2  0  
 4104  33 12  42  7  6  
MiceBlast + Pro Imm Neut Mat Neut Erythroid LymphEosin
Control  2.0 ± 0.7  16.4 ± 2.4  27.0 ± 5.0   40.3 ± 6.5  12.1 ± 1.9 2.3 ± 0.9  
PR  81.3 ± 8.1   4.5 ± 2.6 0.7 ± 0.7   8.7 ± 7.7   4.5 ± 2.2 0.3 ± 0.3  
PRm4  65.7 ± 27.1  13.1 ± 14.4 12.7 ± 17.5   3.5 ± 2.4   4.4 ± 2.4 0.5 ± 1.1  
Leukemia  
 4042  44.5  37.5  5.5 4  6  2.5  
 4048.3  66.5  11  15.5  0.5 6.5  0  
 4048.5  94.5  0.5  0  3.5  1.5  
 4099  90  4.5  0.5  2.5  2  0  
 4104  33 12  42  7  6  

Data are shown as arithmetic means ± SD. Percentages of nucleated cells were derived from 400 cell differential counts of Wright's Giemsa stained bone marrow smears. Abbreviations: see legend to Table 3. Control n = 6, PR (MRP8-PMLRARα) primary leukemias n = 6, PRm4 (MRP8-PMLRARαm4) primary leukemias n = 5. Bone marrow smears were not available for leukemic mice 4048.2 and 4048.4.

Close Modal

or Create an Account

Close Modal
Close Modal